NASDAQ:CRSP - Crispr Therapeutics SEC Filings & 10K Form

$47.55
+1.45 (+3.15 %)
(As of 08/18/2019 09:47 AM ET)
Today's Range
$45.82
Now: $47.55
$47.99
50-Day Range
$45.83
MA: $48.83
$51.92
52-Week Range
$22.22
Now: $47.55
$59.00
Volume374,100 shs
Average Volume654,003 shs
Market Capitalization$2.60 billion
P/E RatioN/A
Dividend YieldN/A
Beta3.11

SEC Filings

Crispr Therapeutics (NASDAQ:CRSP) SEC Filings

DateFilerForm TypeView
08/05/2019
4:49 PM
Crispr Therapeutics (Issuer)
Ho Tony W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/29/2019
3:32 PM
Crispr Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
07/29/2019
3:20 PM
Crispr Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
07/29/2019
3:05 PM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/12/2019
3:13 PM
Crispr Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/12/2019
3:10 PM
Crispr Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/28/2019
1:28 PM
Crispr Therapeutics (Subject)
Versant Venture Capital IV, L.P. (Filed by)
Form SC 13D/A
View Filing
06/26/2019
7:45 AM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/19/2019
3:15 PM
Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/13/2019
7:49 PM
Crispr Therapeutics (Issuer)
High Katherine A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/13/2019
7:42 PM
Crispr Therapeutics (Issuer)
High Katherine A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
06/13/2019
4:07 PM
Behbahani Ali (Reporting)
Crispr Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/13/2019
4:05 PM
Bolzon Bradley J PhD (Reporting)
Crispr Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/13/2019
4:05 PM
Crispr Therapeutics (Issuer)
Greene John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/13/2019
4:04 PM
CAGNONI PABLO J (Reporting)
Crispr Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/13/2019
4:04 PM
Crispr Therapeutics (Issuer)
George Simeon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/13/2019
3:44 PM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/12/2019
3:16 PM
Crispr Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/07/2019
3:04 PM
Crispr Therapeutics (Subject)
VERTEX PHARMACEUTICALS INC / MA (Filed by)
Form SC 13D/A
View Filing
06/06/2019
4:20 PM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/04/2019
3:25 PM
Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/30/2019
3:07 PM
Crispr Therapeutics (Filer)
Form DEFA14A
View Filing
04/29/2019
3:05 PM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/29/2019
6:27 AM
Crispr Therapeutics (Filer)
Form PRER14A
View Filing
04/23/2019
1:34 PM
Crispr Therapeutics (Filer)
Form PRER14A
View Filing
04/09/2019
3:15 PM
Crispr Therapeutics (Filer)
Form PRE 14A
View Filing
03/07/2019
3:17 PM
Crispr Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/07/2019
3:14 PM
Crispr Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/07/2019
3:14 PM
Crispr Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/07/2019
3:12 PM
Crispr Therapeutics (Issuer)
Ho Tony W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/07/2019
3:11 PM
Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/27/2019
3:10 PM
Crispr Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/25/2019
4:32 PM
Crispr Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
02/25/2019
7:16 AM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/25/2019
7:15 AM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/12/2019
9:21 AM
Crispr Therapeutics (Subject)
New Enterprise Associates 15, L.P. (Filed by)
Form SC 13G/A
View Filing
01/18/2019
3:32 PM
Crispr Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
Form 4/A
View Filing
01/10/2019
3:09 PM
Crispr Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/03/2019
3:32 PM
Crispr Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/28/2018
3:34 PM
Crispr Therapeutics (Issuer)
Vertex Pharmaceuticals Ltd (0001761216) (Reporting)
VERTEX PHARMACEUTICALS INC / MA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/28/2018
3:30 PM
Crispr Therapeutics (Subject)
VERTEX PHARMACEUTICALS INC / MA (Filed by)
Form SC 13D/A
View Filing
12/26/2018
3:35 PM
Crispr Therapeutics (Issuer)
Vertex Pharmaceuticals Ltd (0001761216) (Reporting)
VERTEX PHARMACEUTICALS INC / MA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/26/2018
3:33 PM
Crispr Therapeutics (Subject)
VERTEX PHARMACEUTICALS INC / MA (Filed by)
Form SC 13D/A
View Filing
12/21/2018
4:16 PM
Crispr Therapeutics (Issuer)
Vertex Pharmaceuticals Ltd (0001761216) (Reporting)
VERTEX PHARMACEUTICALS INC / MA (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
12/21/2018
4:14 PM
Crispr Therapeutics (Subject)
VERTEX PHARMACEUTICALS INC / MA (Filed by)
Form SC 13D
View Filing
12/19/2018
3:22 PM
Crispr Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/11/2018
3:29 PM
Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/03/2018
4:29 PM
Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/30/2018
10:08 AM
Crispr Therapeutics (Filer)
Form CT ORDER
View Filing
11/07/2018
4:22 PM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/10/2018
4:25 PM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/24/2018
7:23 PM
Crispr Therapeutics (Filer)
Form 424B5
View Filing
09/24/2018
4:27 PM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/21/2018
3:16 PM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/21/2018
3:10 PM
Crispr Therapeutics (Filer)
Form 424B5
View Filing
09/19/2018
3:21 PM
Crispr Therapeutics (Filer)
Form 424B5
View Filing
09/19/2018
3:02 PM
Crispr Therapeutics (Filer)
Form S-3ASR
View Filing
09/17/2018
7:13 AM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/11/2018
8:00 AM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/04/2018
5:33 PM
Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/31/2018
3:13 PM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/31/2018
3:03 PM
Crispr Therapeutics (Filer)
Form 424B5
View Filing
08/07/2018
4:10 PM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/03/2018
4:43 PM
Crispr Therapeutics (Issuer)
Ho Tony W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/05/2018
5:25 PM
CAGNONI PABLO J (Reporting)
Crispr Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/19/2018
3:55 PM
Crispr Therapeutics (Issuer)
George Simeon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
8:46 PM
Behbahani Ali (Reporting)
Crispr Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
8:41 PM
Crispr Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
8:40 PM
Bolzon Bradley J PhD (Reporting)
Crispr Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
8:39 PM
Crispr Therapeutics (Issuer)
Woiwode Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
8:38 PM
Crispr Therapeutics (Issuer)
Ho Tony W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
8:37 PM
Crispr Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
8:36 PM
Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
8:35 PM
CAGNONI PABLO J (Reporting)
Crispr Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/07/2018
6:23 PM
Crispr Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
Form 4/A
View Filing
06/07/2018
3:36 PM
Crispr Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/05/2018
7:20 PM
Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/01/2018
4:05 PM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/30/2018
3:37 PM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/21/2018
3:54 PM
Crispr Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/17/2018
4:15 PM
Bolzon Bradley J PhD (Reporting)
Crispr Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/17/2018
4:11 PM
Crispr Therapeutics (Issuer)
Woiwode Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/15/2018
7:04 PM
Crispr Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/09/2018
4:15 PM
Crispr Therapeutics (Issuer)
Woiwode Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/09/2018
4:14 PM
Bolzon Bradley J PhD (Reporting)
Crispr Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/08/2018
6:43 AM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/08/2018
6:26 AM
Crispr Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/02/2018
5:00 PM
Crispr Therapeutics (Issuer)
Woiwode Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/02/2018
5:00 PM
Bolzon Bradley J PhD (Reporting)
Crispr Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/30/2018
7:58 PM
Bolzon Bradley J PhD (Reporting)
Crispr Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/30/2018
7:57 PM
Crispr Therapeutics (Issuer)
Woiwode Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/26/2018
4:01 PM
Crispr Therapeutics (Issuer)
Woiwode Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/26/2018
3:57 PM
Bolzon Bradley J PhD (Reporting)
Crispr Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/26/2018
3:44 PM
Crispr Therapeutics (Issuer)
Versant Affiliates Fund V, L.P. (Reporting)
Versant Ophthalmic Affiliates I, L.P. (Reporting)
Versant Venture Capital V , LP (0001612235) (Reporting)
Versant Venture Capital V, L.P. (Reporting)
Versant Ventures V, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/24/2018
6:44 PM
Crispr Therapeutics (Issuer)
Versant Affiliates Fund V, L.P. (Reporting)
Versant Ophthalmic Affiliates I, L.P. (Reporting)
Versant Side Fund IV, L.P. (Reporting)
Versant Venture Capital IV, L.P. (Reporting)
Versant Venture Capital V , LP (0001612235) (Reporting)
Versant Venture Capital V, L.P. (Reporting)
Versant Ventures IV, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/24/2018
6:42 PM
Crispr Therapeutics (Issuer)
Woiwode Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/24/2018
6:41 PM
Bolzon Bradley J PhD (Reporting)
Crispr Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/18/2018
3:50 PM
Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/18/2018
3:49 PM
Crispr Therapeutics (Filer)
Form DEFA14A
View Filing
04/18/2018
3:44 PM
Crispr Therapeutics (Filer)
Form DEF 14A
View Filing
This page was last updated on 8/18/2019 by MarketBeat.com Staff

Featured Article: What is a Buy-Side Analyst?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel